Agios' Lewis Cant­ley re­turns with a new com­pa­ny and, he claims, a ma­jor on­co­log­i­cal dis­cov­ery

Lewis Cant­ley was a bit con­fused when he got an email from a grad­u­ate stu­dent who want­ed to come to his Cor­nell lab and work on a se­mi-ob­scure phe­nom­e­non in cell bi­ol­o­gy: Lag­ging chro­mo­somes.

“I said ‘I don’t know much about lag­ging chro­mo­somes,'” Cant­ley, who be­came fa­mous for dis­cov­er­ing the PI3K path­way and its role in can­cer, told End­points News. 

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER